AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. ZVSA
  4. [S-1/A] ZyVersa Therapeutics, Inc. Amends IPO Registration Statement

[S-1/A] ZyVersa Therapeutics, Inc. Amends IPO Registration Statement

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
S-1/A

Filing content is currently unavailable.

Source:

Stock ZVSA logo
ZyVersa Therapeutics Inc

OTC:ZVSA

ZVSA Rankings

#6413 Ranked by Market Cap
N/A Ranked by Dividends

ZVSA Latest News

Aug 13, 2025
ZyVersa Therapeutics Reports Second Quarter 2025 Financial Results and Highlights Key Near-term Value-building Milestones
Jul 21, 2025
ZyVersa Therapeutics CEO Issues Mid-year Shareholder Letter Highlighting Recent Corporate Developments and R&D Progress
Jul 8, 2025
ZyVersa Therapeutics Announces a Warrant Inducement Transaction for $2.0 Million in Gross Proceeds
Jul 8, 2025
ZyVersa Therapeutics Supports FDA-Authorized Emergency Compassionate Use of Cholesterol Efflux Mediator™ VAR 200 in a Patient with ApoCII Amyloidosis
Jun 26, 2025
ZyVersa Therapeutics Announces First Clinical Site Activation, Initiating Patient Recruitment for Cholesterol Efflux Mediator� VAR 200’s Phase 2a Clinical Trial in Patients with Diabetic Kidney Disease (DKD)

ZVSA Latest SEC Filings

Jul 16, 2025
[Form 4] ZyVersa Therapeutics, Inc. Insider Trading Activity
Jul 16, 2025
[8-K] ZyVersa Therapeutics, Inc. Reports Material Event
Jul 15, 2025
[Form 4] ZyVersa Therapeutics, Inc. Insider Trading Activity
Jul 15, 2025
[Form 4] ZyVersa Therapeutics, Inc. Insider Trading Activity
Jul 15, 2025
[Form 4] ZyVersa Therapeutics, Inc. Insider Trading Activity

ZVSA Stock Data

3.12M
4.87M
0.13%
7.28%
7.37%
Biotechnology
Pharmaceutical Preparations
United States
SOMERVILLE